Suppr超能文献

相似文献

1
Rapamycin, but not cyclosporine or FK506, alters natural killer cell function.
Transplantation. 2008 Jan 15;85(1):145-9. doi: 10.1097/01.tp.0000296817.28053.7b.
3
Immunological aspects of allogeneic and autologous mesenchymal stem cell therapies.
Hum Gene Ther. 2011 Dec;22(12):1587-91. doi: 10.1089/hum.2011.039. Epub 2011 Aug 10.
9
The effects of rapamycin in murine peripheral nerve isografts and allografts.
Plast Reconstr Surg. 2002 Jun;109(7):2405-17. doi: 10.1097/00006534-200206000-00035.

引用本文的文献

1
Enhancement of the Anticancer Ability of Natural Killer Cells through Allogeneic Mitochondrial Transfer.
Cancers (Basel). 2023 Jun 17;15(12):3225. doi: 10.3390/cancers15123225.
3
Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants.
Nat Commun. 2019 Nov 25;10(1):5350. doi: 10.1038/s41467-019-13113-5.
4
Current Flow Cytometric Assays for the Screening and Diagnosis of Primary HLH.
Front Immunol. 2019 Jul 23;10:1740. doi: 10.3389/fimmu.2019.01740. eCollection 2019.
5
Biological effects of cyclosporin A on CD3CD161 and CD3CD161 lymphocytes.
Mol Cell Biochem. 2019 Aug;458(1-2):159-169. doi: 10.1007/s11010-019-03539-2. Epub 2019 Apr 24.
7
Small-Molecule Immunosuppressive Drugs and Therapeutic Immunoglobulins Differentially Inhibit NK Cell Effector Functions .
Front Immunol. 2019 Mar 27;10:556. doi: 10.3389/fimmu.2019.00556. eCollection 2019.
8
The Role of NK Cells in Pig-to-Human Xenotransplantation.
J Immunol Res. 2017;2017:4627384. doi: 10.1155/2017/4627384. Epub 2017 Dec 19.
9
Low incidence of severe cGvHD and late NRM in a phase II trial of thymoglobulin, tacrolimus and sirolimus for GvHD prevention.
Bone Marrow Transplant. 2017 Sep;52(9):1304-1310. doi: 10.1038/bmt.2017.95. Epub 2017 Jun 5.
10
The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma.
Oncoimmunology. 2015 Oct 29;5(5):e1108513. doi: 10.1080/2162402X.2015.1108513. eCollection 2016 May.

本文引用的文献

1
The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations.
Blood. 2007 Sep 1;110(5):1530-9. doi: 10.1182/blood-2006-10-048173. Epub 2007 May 10.
3
The changing role of natural killer cells in solid organ rejection and tolerance.
Transplantation. 2006 Mar 27;81(6):811-7. doi: 10.1097/01.tp.0000202844.33794.0e.
4
Role of natural killer cell subsets in cardiac allograft rejection.
Am J Transplant. 2006 Mar;6(3):505-13. doi: 10.1111/j.1600-6143.2005.01226.x.
9
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.
Science. 2002 Mar 15;295(5562):2097-100. doi: 10.1126/science.1068440.
10
Innate immune responses to transplants: a significant variable with cadaver donors.
Immunity. 2001 Apr;14(4):369-76. doi: 10.1016/s1074-7613(01)00117-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验